Clinical Trials Logo

Microtia clinical trials

View clinical trials related to Microtia.

Filter by:

NCT ID: NCT03771066 Recruiting - Insulin Sensitivity Clinical Trials

Bisphenol A and Muscle Insulin Sensitivity

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

This study examine oral bisphenol A consumption on muscle insulin sensitivity and hepatic glucose suppression. Half of the participants will receive a diet plus BPA and the other half will receive a diet plus no bisphenol A.

NCT ID: NCT03729427 Not yet recruiting - Anesthesia Clinical Trials

Rib Microtia and the Erector Spinae Plane (ESP) Block

Start date: January 2024
Phase: N/A
Study type: Interventional

The erector spinae plane block is a novel regional anesthetic technique that allows for analgesia of the thorax and abdomen with a peripheral nerve block. This study is being performed to assess the effectiveness of this technique in reducing post-operative pain scores and opiate requirements in pediatric and adult patients undergoing rib cartilage grafting surgeries.

NCT ID: NCT03624608 Suspended - Microtia Clinical Trials

Evaluation of the Auryzon Devices in the Optimization of Ear and Nose Reconstruction Procedures

Start date: March 1, 2020
Phase: N/A
Study type: Interventional

This study evaluates the efficacy of the AuryzoN devices in the ear and nose reconstruction surgeries, both in terms of operative time and overall quality of reconstruction. Research participants will undergo reconstruction either using the AuryzoN device or through current methods (traditional manual processing) at the discretion of their surgeon prior to the start of surgery.

NCT ID: NCT02518035 Recruiting - Scar Clinical Trials

Silicone Gel to Improve Scar in Microtia Patients

Start date: July 2015
Phase: Phase 4
Study type: Interventional

Effort to reduce post-surgical scar is especially important for microtia patients. Even the scar lies posterior to ear auricle, but hypertrophic scar contracture may limit the ear auricle projection. If the scar is hypertrophic and conspicuous, this stigmata will accompanies the child for many years.The main objective aim of this study is to examine whether post-operative use of silicone gel can improve scar formation for microtia reconstruction scars.

NCT ID: NCT02224677 Completed - Microtia Clinical Trials

Craniofacial Microsomia: Longitudinal Outcomes in Children Pre-Kindergarten (CLOCK)

CLOCK
Start date: November 2013
Phase:
Study type: Observational

This study is a multi-center, longitudinal cohort study of 125 infants with craniofacial microsomia (CFM) and 100 infants without craniofacial anomalies. Participants will undergo a series of evaluations between 0-3 years of age to comprehensively evaluate the developmental status of infants and toddlers with CFM. This research design will also explore specific pathways by which CFM may lead to certain outcomes. Specifically, the study explores (1) the longitudinal relations between facial asymmetry and emotion-related facial movements and socialization; and (2) associations among ear malformations, hearing and speech deficits and cognitive outcomes. Results of this research will ultimately lead to future investigations that assess new interventions and corresponding changes in current standards of care for children with CFM.

NCT ID: NCT00958802 Completed - Microtia Clinical Trials

Tissue Engineering Microtia Auricular Reconstruction: in Vitro and in Vivo Studies

Start date: May 2009
Phase: Phase 0
Study type: Interventional

Platelet-rich plasma (PRP) has mixed growth factors such as TGF-ß1 and TGF-ß2, vascular epithelial growth factor (VEGF), platelet-derived growth factor (PDGF), and insulin-like growth factor (IGF). These growth factors appear to play an important role in wound healing and are assumed as promoters of tissue regeneration. Moreover, PRP was used as injectable scaffold seeded with chondrocytes to regenerate cartilage. In their previous study, the investigators concluded that growth factors in PRP can effectively react as a growth factor cocktail to induce human nucleus pulposus proliferation and differentiation, and also promote tissue-engineered nucleus pulposus formation. The investigators also have a hypothesis that PRP can promote tissue-engineered microtia auricular cartilage formation. TGF- ß1 exists in the highest concentration and is more important among all of the growth factors released from PRP. So TGF- ß1 can be used as the core ingredient and the indicator for applying PRP in these studies. The aim of this study was to compare the histological and biochemical character of microtia chondrocytes treated with and without PRP.